Arbutus Biopharma (NASDAQ:ABUS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Arbutus Biopharma beat estimated earnings by 31.25%, reporting an EPS of $-0.11 versus an estimate of $-0.16.
Revenue was up $10.47 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 4.75% drop in the share price the next day.
Here’s a look at Arbutus Biopharma’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.19 | -0.24 | -0.22 | -0.23 |
| EPS Actual | -0.15 | -0.24 | -0.23 | -0.21 |
| Revenue Estimate | 2.87M | 2.38M | 2.12M | 3.31M |
| Revenue Actual | 3.21M | 3.34M | 2.33M | 2.11M |
To track all earnings releases for Arbutus Biopharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
